This is just a gamble like most other early stage bio companies. There would be a lot like myself stuck with an average multiples higher than what it is atm. Good results still won’t get me back near my average. Not sure anybody would have any idea whether the results could be good or bad. Let’s hope they are positive
Ann: Phase 2a/b clinical trial update, page-11
Add ILA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.025(31.3%) |
Mkt cap ! $13.32M | |||
| Open | High | Low | Value | Volume |
| 9.9¢ | 13.0¢ | 9.8¢ | $452.6K | 4.142M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7707 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 28571 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| ILA (ASX) Chart |